Tag: drug development

A surprise finding from our Wladek Minor should improve the process of drug development and help prevent harmful drug interactions.

A promising cancer drug that's being developed based on a discovery by our Kimberly Kelly, PhD, is attracting major interest -- to the tune of $25 million.

The federal Food and Drug Administration has approved a new single-dose drug, baloxavir marboxil, that can shorten the duration of the flu. It's the first new drug of its type in 20 years. Our Frederick G. Hayden, MD, and his colleagues found that the drug, developed by pharma company Shinogi,…

Our J. Julius Zhu, PhD, and his colleagues have found a way to create drugs without side effects. Basically, they've developed a lab technique that will add a whole new layer of precision to the concept of "precision medicine." The technique is built on their discovery that the same molecule…